These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3165604)

  • 21. Progress in antiviral drug and vaccine development assessed at international AIDS conference.
    Miller JL
    Clin Pharm; 1987 Aug; 6(8):592,595-6. PubMed ID: 2826072
    [No Abstract]   [Full Text] [Related]  

  • 22. AIDS drug assistance program.
    N Y State J Med; 1988 Feb; 88(2):91. PubMed ID: 3422714
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiviral drugs other than zidovudine and immunomodulating therapies in human immunodeficiency virus infection. An overview.
    Clumeck N; Hermans P
    Am J Med; 1988 Aug; 85(2A):165-72. PubMed ID: 2457313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A little more to improve safety and efficiency of AZT in AIDS therapy.
    Camsonne R; Hurrault de Ligny B; Letellier P
    Int J Clin Pharmacol Ther Toxicol; 1987 Dec; 25(12):683. PubMed ID: 3481360
    [No Abstract]   [Full Text] [Related]  

  • 26. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).
    Jackson GG; Paul DA; Falk LA; Rubenis M; Despotes JC; Mack D; Knigge M; Emeson EE
    Ann Intern Med; 1988 Feb; 108(2):175-80. PubMed ID: 3124680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new HIV/AIDS drug.
    J Ark Med Soc; 1996 Jan; 92(8):407. PubMed ID: 8582889
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
    Chaisson RE; Leuther MD; Allain JP; Nusinoff-Lehrman S; Boone GS; Feigal D; Volberding P
    Arch Intern Med; 1988 Oct; 148(10):2151-3. PubMed ID: 3263098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commercial venture to speed up AIDS drug tests in California.
    Barinaga M
    Nature; 1988 May; 333(6170):196. PubMed ID: 3285222
    [No Abstract]   [Full Text] [Related]  

  • 31. German-Austrian Guidelines for HIV-therapy during pregnancy--status: May/June 1998--common statement of the Deutsche AIDS-Gesellschaft (DAIG) and the Osterreichische AIDS-Gesellschaft (OAG).
    Brockmeyer N
    Eur J Med Res; 1999 Jan; 4(1):35-42. PubMed ID: 9892574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and tolerance of intermittent intravenous and oral zidovudine therapy in human immunodeficiency virus-infected pediatric patients. Pediatric Zidovudine Phase I Study Group.
    McKinney RE; Pizzo PA; Scott GB; Parks WP; Maha MA; Lehrman SN; Riggs M; Eddy J; Lane BA; Eppes SC
    J Pediatr; 1990 Apr; 116(4):640-7. PubMed ID: 2181102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of human immunodeficiency virus infections.
    Pomerantz RJ; Schooley RT
    Clin Lab Med; 1987 Dec; 7(4):793-813. PubMed ID: 2446817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.
    Musicco M; Lazzarin A; Nicolosi A; Gasparini M; Costigliola P; Arici C; Saracco A
    Arch Intern Med; 1994 Sep; 154(17):1971-6. PubMed ID: 8074601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AZT helpful in HIV infection.
    N Z Med J; 1988 Apr; 101(844):222. PubMed ID: 3163108
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).
    Yarchoan R; Perno CF; Thomas RV; Klecker RW; Allain JP; Wills RJ; McAtee N; Fischl MA; Dubinsky R; McNeely MC
    Lancet; 1988 Jan; 1(8577):76-81. PubMed ID: 2891981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIDS drug shows promise in preliminary clinical trial.
    Marx JL
    Science; 1986 Mar; 231(4745):1504-5. PubMed ID: 3006242
    [No Abstract]   [Full Text] [Related]  

  • 38. AIDS. Treatment strategies and the Minnesota AIDS Clinical Trials Unit.
    Thurn JR; Henry K; Balfour HH
    Minn Med; 1988 May; 71(5):289-92. PubMed ID: 2841562
    [No Abstract]   [Full Text] [Related]  

  • 39. Possible drug interaction during therapy with azidothymidine and acyclovir for AIDS.
    Bach MC
    N Engl J Med; 1987 Feb; 316(9):547. PubMed ID: 3468354
    [No Abstract]   [Full Text] [Related]  

  • 40. Progress in the development of antiviral therapy for HTLV-III-associated diseases.
    Yarchoan R; Broder S
    Important Adv Oncol; 1987; ():293-311. PubMed ID: 2841232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.